The medical devices industry continues to be a hotbed of innovation, with activity driven by increased need for homecare, preventative treatments, early diagnosis, reducing patient recovery times and improving outcomes, as well as a growing importance of technologies such as machine learning, augmented reality, 5G and digitalisation. In the last three years alone, there have been over 450,000 patents filed and granted in the medical devices industry, according to GlobalData’s report on Internet of Things in Medical Devices: Neuromuscular activity analysis.
However, not all innovations are equal and nor do they follow a constant upward trend. Instead, their evolution takes the form of an S-shaped curve that reflects their typical lifecycle from early emergence to accelerating adoption, before finally stabilising and reaching maturity.
Identifying where a particular innovation is on this journey, especially those that are in the emerging and accelerating stages, is essential for understanding their current level of adoption and the likely future trajectory and impact they will have.
150+ innovations will shape the medical devices industry
According to GlobalData’s Technology Foresights, which plots the S-curve for the medical devices industry using innovation intensity models built on over 550,000 patents, there are 150+ innovation areas that will shape the future of the industry.
Within the emerging innovation stage, ingestible sensors, wireless gastric stimulation devices, and remote nerve stimulation devices are disruptive technologies that are in the early stages of application and should be tracked closely. dosage monitoring inhalators, programmable infusion pumps, and athletic monitoring sensors are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas are blood glucose sensors and medical emergency response systems, which are now well established in the industry.
Innovation S-curve for Internet of Things in the medical devices industry
Neuromuscular activity analysis is a key innovation area in Internet of Things
Neuromuscular activity analysis is a profound method for monitoring neuromuscular transmission. It checks the neuromuscular function by stimulating a reachable peripheral motor nerve and further measures the evoked response of the muscles innervated by it. This evaluation method can be used to determine the health of muscles and related motor neurons, detect neuromuscular abnormalities and assess the cause of certain symptoms.
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 660+ companies, spanning technology vendors, established medical devices companies, and up-and-coming start-ups engaged in the development and application of neuromuscular activity analysis.
Key players in neuromuscular activity analysis – a disruptive innovation in the medical devices industry
‘Application diversity’ measures the number of different applications identified for each relevant patent and broadly splits companies into either ‘niche’ or ‘diversified’ innovators.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
Patent volumes related to neuromuscular activity analysis
Source: GlobalData Patent Analytics
Baxter International is one of the leading patent filers in the field of neuromuscular activity analysis. Some other key patent filers in the field include Koninklijke Philips and Medtronic.
In terms of application diversity, Teva Pharmaceutical Industries leads the pack, followed by ResMed and Microsoft. By means of geographic reach, Teva Pharmaceutical Industries holds the top position, followed by Stryker and NIKE in the second and third spots, respectively.
The rise in the number of neuromuscular disorders is increasing the need for adequate therapy that will reduce the risk of residual neuromuscular blockades leading to the overall growth of the neurology devices market. Neuromuscular activity analysis provides doctors with a crucial insight, enabling them to provide a more predictable and accurate treatment approach, thereby leading to improved patient care.
To further understand the key themes and technologies disrupting the medical devices industry, access GlobalData’s latest thematic research report on Medical Devices.